Cerenome (CNSY) EBITDA Margin (QoQ) (2011 - 2026)
Powered by 
Analysis
Cerenome (CNSY) EBITDA Margin (QoQ) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -151,114.00 |
| Mar 31, 2026 | -27,247.00 |
| Dec 31, 2025 | -9,921.00 |
| Sep 30, 2025 | -21,018.00 |
| Jun 30, 2025 | 22,325.00 |
| Mar 31, 2025 | -5,770.00 |
| Dec 31, 2024 | -1,528.00 |
| Sep 30, 2024 | 2,813.00 |
| Jun 30, 2024 | -9,233.00 |
| Mar 31, 2024 | 9,711.00 |
| Dec 31, 2023 | -21,994.00 |
| Sep 30, 2023 | 453.00 |
| Jun 30, 2023 | 85,478.00 |
| Mar 31, 2023 | 275,686.00 |
| Dec 31, 2022 | 328,802.00 |
| Mar 31, 2019 | -17,379.00 |
| Dec 31, 2018 | 12,524.00 |
| Sep 30, 2018 | 2,014.00 |
| Jun 30, 2018 | 31,565.00 |
| Mar 31, 2018 | -4,701.00 |